West Pharmaceutical Services, Inc.
Hedge Funds Holdings
Last updated:
West Pharmaceutical Services, Inc.‘s stocks are currently a part of 630 hedge funds’ portfolios, which represents 88.87% of the total amount of its stocks outstanding. This makes up a total of 67.54M shares of West Pharmaceutical Services, Inc.. Compared to the previous quarter, the number fell by -3.13% or -2.18M shares fewer. As for the holding position changes, 35.71% (225) of current hedge fund investors increased the number of shares held, 42.06% (265) of current holders sold a part of the shares held, and 17.14% (108) closed the holdings completely. 56 hedge funds are new holders of West Pharmaceutical Services, Inc. stock in Q2 2022, it is 8.89% of total holders.
Hedge funds holding West Pharmaceutical Services (Q3 2017 – Q2 2022)
Q3 2017 | 302 |
---|---|
Q4 2017 | 336 |
Q1 2018 | 321 |
Q2 2018 | 323 |
Q3 2018 | 352 |
Q4 2018 | 353 |
Q1 2019 | 377 |
Q2 2019 | 371 |
Q3 2019 | 401 |
Q4 2019 | 437 |
Q1 2020 | 461 |
Q2 2020 | 511 |
Q3 2020 | 559 |
Q4 2020 | 578 |
Q1 2021 | 575 |
Q2 2021 | 622 |
Q3 2021 | 649 |
Q4 2021 | 710 |
Q1 2022 | 689 |
Q2 2022 | 630 |
Hedge funds changes in West Pharmaceutical Services positions (Q3 2017 – Q2 2022)
Q3 2017 | 36 | 119 | 96 | 41 | 10 |
---|---|---|---|---|---|
Q4 2017 | 62 | 113 | 105 | 25 | 31 |
Q1 2018 | 36 | 119 | 104 | 47 | 15 |
Q2 2018 | 40 | 100 | 119 | 36 | 28 |
Q3 2018 | 57 | 119 | 108 | 27 | 41 |
Q4 2018 | 53 | 133 | 101 | 51 | 15 |
Q1 2019 | 66 | 141 | 96 | 42 | 32 |
Q2 2019 | 42 | 134 | 122 | 42 | 31 |
Q3 2019 | 61 | 142 | 134 | 32 | 32 |
Q4 2019 | 85 | 146 | 141 | 39 | 26 |
Q1 2020 | 68 | 167 | 159 | 41 | 26 |
Q2 2020 | 114 | 177 | 163 | 60 | -3 |
Q3 2020 | 97 | 195 | 208 | 46 | 13 |
Q4 2020 | 83 | 234 | 192 | 60 | 9 |
Q1 2021 | 75 | 216 | 198 | 73 | 13 |
Q2 2021 | 100 | 219 | 209 | 51 | 43 |
Q3 2021 | 90 | 233 | 232 | 52 | 42 |
Q4 2021 | 132 | 269 | 222 | 64 | 23 |
Q1 2022 | 69 | 242 | 269 | 84 | 25 |
Q2 2022 | 56 | 225 | 265 | 108 | -24 |
Hedge funds changes in West Pharmaceutical Services stock options (Q3 2017 – Q2 2022)
Q3 2017 | 1,011,000 | 48,000 |
---|---|---|
Q4 2017 | 1,154,000 | 809,000 |
Q1 2018 | 0 | 0 |
Q2 2018 | 1,698,000 | 1,976,000 |
Q3 2018 | 2,037,000 | 14,088,000 |
Q4 2018 | 2,389,000 | 5,553,000 |
Q1 2019 | 3,063,000 | 24,642,000 |
Q2 2019 | 5,019,000 | 47,616,000 |
Q3 2019 | 7,212,000 | 46,494,000 |
Q4 2019 | 11,574,000 | 2,105,000 |
Q1 2020 | 14,188,000 | 7,063,000 |
Q2 2020 | 23,616,000 | 13,148,000 |
Q3 2020 | 19,983,000 | 6,871,000 |
Q4 2020 | 16,858,000 | 20,455,000 |
Q1 2021 | 19,035,000 | 24,933,000 |
Q2 2021 | 28,237,000 | 51,828,000 |
Q3 2021 | 55,940,000 | 66,956,000 |
Q4 2021 | 63,284,000 | 82,228,000 |
Q1 2022 | 279,368,000 | 1,782,067,035,000 |
Q2 2022 | 61,497,000 | 20,469,000 |